Key takeaways
- What happened next turned a bad call into a case study in how a correct diagnosis can still destroy a portfolio.
- Stock in this story: FMC. See its latest quote and chart on Trade Conquest.
- Reported by 24/7 Wall St.. Open the full story for every detail.
Goldman Sachs slashed its price target by more than half and still told clients to buy. What happened next turned a bad call into a case study in how a correct diagnosis can still destroy a portfolio.
See the latest quote, chart and news for FMC.
